Harbour BioMed Co. Ltd.   Report issue

For profit Phase 1 Phase 3
Founded: Shanghai China (2016)

Organization Overview

First Clinical Trial
2019
NCT04092907
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Harbour BioMed (Guangzhou) Co. Ltd.